Skip to content

The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion

The Effect of Perioperative Cardiac Output-guided Goal-directed Hemodynamic Therapy (GDT) on Perioperative Oxygen Delivery, Consumption, and Microcirculatory Perfusion in Comparison to Routine Hemodynamic Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05090254
Acronym
CUSTOM
Enrollment
78
Registered
2021-10-22
Start date
2021-08-01
Completion date
2022-05-31
Last updated
2022-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caridac Output-guided Goal-directed Hemodynamic Therapy, Major Non-cardiac Surgery, Microcirculatory Perfusion, Oxygen Consumption, Oxygen Delivery, Postoperative Acute Kidney Injury, Postoperative Acute Myocardial Injury

Keywords

non-cardiac surgery, oxygen consumption, oxygen delivery, microcirculatory perfusion, goal-directed hemodynamic therapy

Brief summary

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

Detailed description

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. With technological advancements a distinct monitoring of oxygen delivery and consumption as well as microcirculatory perfusion in the perioperative period has become possible. Using new technologies, a detailed understanding of the effect of cardiac output-guided goal-directed therapy on perioperative oxygen delivery and consumption as well as microcirculatory perfusion is of vital importance to further develop and improve perioperative hemodynamic treatment strategies. In this pilot randomized-controlled trial, the investigators therefore aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

Interventions

OTHERTreatment algorithms targeting cardiac output

Treatment algorithms targeting maximization or personalization of cardiac output

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia * Expected duration of surgery at least 120 minutes * Planned postoperative monitoring in intensive care unit

Exclusion criteria

* Emergency surgery * Age \<18 years * Body weight \<50 kg * Pregnancy * Atrial fibrillation * Planned patient positioning in other position than supine position * Surgery within the last 30 days * Inaccessibility of the head during surgery * Peripheral artery disease stage ≥IIb * Chronic vasculitis * Supraglottic airway management * Enterostomy repair surgery

Design outcomes

Primary

MeasureTime frameDescription
Perioperative changes in oxygen deliveryafter induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgeryassessed via blood gas analysis
Perioperative changes in oxygen consumptionbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgeryassessed via indirect calorimetry

Secondary

MeasureTime frameDescription
Perioperative changes of microcirculationbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgeryassessed via Incident Darkfield technology
Perioperative changes in cardiac outputbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgeryassessed via pulse wave analysis

Other

MeasureTime frameDescription
Incidence of acute kidney injurybaseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgeryassessed via blood samples
Perioperative changes in urethral perfusion indexafter induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgeryassessed via urethral photoplethysmography
Incidence of postoperative myocardial injurybaseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgeryassessed via blood samples

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026